Multi-Arm Therapeutic Study in Pre-ICU Patients Admitted with COVID-19

The TACTIC-R clinical trial is testing whether existing drugs, which are already used to treat other immune-related conditions, can prevent the development of severe symptoms in patients hospitalised with confirmed COVID-19. This approach, known as repurposing, is a way of finding out whether existing therapies, which are likely to be readily available in hospitals, are effective in treating the disease.